Senior Director, US Marketing Operations

Waltham, MA (On-site)

$224K/yr – $290K/yrSenior Level15+ years expFull time

Posted 2 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own enterprise marketing operations at scale across brands and therapeutic areas, aligning governance, capacity planning, and portfolio performance with cross‑functional leaders.

  • Drive the enterprise operations model, including capability roadmap, vendor strategy, and SOPs.
  • Coordinate with Finance, Procurement, and IT to ensure resourcing, tools, and integrated planning.
  • Elevate ongoing performance through enterprise KPIs and risk-aware tradeoffs to support launches and growth.

Job Description

Responsibilities - Sets direction and owns the enterprise marketing operations operating model across brands and therapeutic areas - Partners with Finance, Procurement, and IT on resourcing, tools, and integrated planning - Builds and governs a multi-year capability roadmap to support launches and portfolio growth - Drives prioritization, metrics, and performance management across Marketing Operations - Advises senior leadership on operational performance, risk, and tradeoffs - Sets and scales the PRC/MLR operating model, including governance, capacity planning, vendor strategy, and SOPs - Owns enterprise KPIs and continuous improvement initiatives - Is accountable for sustained on-time performance, quality, surge readiness, and cross-brand prioritization - Sets enterprise governance for sponsorships and grants, ensuring consistent controls, portfolio visibility, and audit-ready processes - Owns portfolio-level governance for peer-to-peer education, including operating standards, compliance guardrails, and vendor oversight Requirements - Bachelor’s degree in a relevant discipline required; Master’s degree preferred - 15+ years of progressive experience in pharmaceutical or biotechnology marketing operations, commercial operations, or related functions, or equivalent experience - Demonstrated experience leading enterprise‑ or portfolio‑level operating models in highly regulated environments - Extensive experience with promotional compliance, governance, and risk management across multiple brands or therapeutic areas - Proven experience leading, coaching, and developing senior‑level leaders and managers - Strategic, enterprise‑level leader with the ability to define vision, set standards, and govern execution at scale - Strong judgment in navigating complex, ambiguous operational challenges while balancing speed, quality, and compliance - Ability to influence senior leaders and executives through clear recommendations, data‑driven insights, and thoughtful tradeoffs - Deep expertise in portfolio prioritization, capacity planning, and resource allocation - Strong understanding of cross‑functional interdependencies and integrated commercial systems Nice_to_have Benefits Compensation - MA Pay Range - $224,000 — $290,000 USD - The pay range reflects the base pay range Dyne reasonably expects to pay for this role at the time of posting. Individual compensation depends on factors such as education, experience, job-related knowledge, and demonstrated skills. About_company - Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as a preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/ , and follow us on X , LinkedIn and Facebook. Other Drops
Dyne Therapeutics logo

Dyne Therapeutics

4.0 Glassdoor

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more https://www.dyne-tx.com/. To view our community guidelines, click here: https://bit.ly/3BYPnpK

Founded in 2018
Waltham, Massachusetts, USA
255 employees (4 in marketing)
75% recommend to a friend
100% CEO approval

Traffic Signals

Monthly Visitors
13.6K
Traffic Source Mix
Search
43%
Direct
46.9%
Referral
5.9%
Social
2.5%
Paid
1.4%

Headcount Trend

Current headcount: ~255

Marketing Team

Marketing Team Size
4 (2% of company)

Funding

Total Funding
$1.1B
Last Raise
$100M
Post IPO Equity, 9 months ago

Funding History

  • Jun 2025
    Post IPO Debt • $100M
  • Jun 2025
    Post IPO Equity • $200M
  • May 2024
    Post IPO Equity • $325.5M

Recent News